Akèy › Sistèm Imunitè ak Twoub
Etid klinik pou Sistèm Imunitè ak Twoub ap rekrite nan Etazini
43 etid pou Sistèm Imunitè ak Twoub ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Washington, DC13 etid
- New York City, NY12 etid
- Boston, MA10 etid
- Philadelphia, PA10 etid
- Houston, TX9 etid
- Atlanta, GA9 etid
- Portland, OR9 etid
- Cleveland, OH8 etid
- Los Angeles, CA8 etid
- Chicago, IL8 etid
- Cedar Rapids, IA6 etid
- Seattle, WA6 etid
- Milwaukee, WI6 etid
- Durham, NC5 etid
- Tampa, FL5 etid
- Baldwin Park, CA5 etid
- Salt Lake City, UT5 etid
- Nashville, TN5 etid
- St. Louis, MO4 etid
- Clifton, NJ4 etid
- Dallas, TX4 etid
- Pittsburgh, PA4 etid
- Norfolk, VA3 etid
- Louisville, KY3 etid
- The Bronx, NY3 etid
- Kansas City, MO3 etid
- Greenville, NC3 etid
- Indianapolis, IN3 etid
- San Diego, CA3 etid
- Columbus, OH3 etid
- Mountain View, CA3 etid
- New Haven, CT3 etid
- Denver, CO3 etid
- Buffalo, NY3 etid
- Cincinnati, OH3 etid
- Richmond, VA3 etid
- Omaha, NE3 etid
- San Francisco, CA3 etid
- Rochester, MN3 etid
- Phoenix, AZ3 etid
Pa eta
- Arizona3 etid
- Arkansas3 etid
- Colorado4 etid
- Connecticut3 etid
- Distrik Columbia3 etid
- Florid11 etid
- Georgia10 etid
- Illinois9 etid
- Indiana4 etid
- Iowa6 etid
- Kalifòni18 etid
- Kentucky4 etid
- Maryland13 etid
- Massachusetts10 etid
- Michigan4 etid
- Minnesota4 etid
- Missouri6 etid
- Nebraska3 etid
- New Jersey6 etid
- New York14 etid
- North Carolina7 etid
- Ohio9 etid
- Oregon9 etid
- Pennsylvania12 etid
- South Carolina3 etid
- Tennessee5 etid
- Texas14 etid
- Utah5 etid
- Virginia6 etid
- Washington7 etid
- Wisconsin6 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07192471Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
Ap rekriteEtid obsèvasyon
Laj 1 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT00001406Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Month – 120 Years · Tout sèks · Mizajou Sep 28, 2026 · NCT00006150Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Ap rekriteFaz 2Volontè an sante akeyi
Laj 4 a 75 · Tout sèks · Mizajou Sep 28, 2026 · NCT02579967Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Ap rekriteFaz 2
Laj 4 a 69 · Tout sèks · Mizajou Sep 28, 2026 · NCT04339777Detection and Characterization of Infections and Infection Susceptibility
Ap rekriteEtid obsèvasyon
1 Month – 100 Years · Tout sèks · Mizajou Sep 28, 2026 · NCT00404560Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 7 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT01568697Genetic Analysis of Immune Disorders
Ap rekriteEtid obsèvasyon
1 Day – 101 Years · Tout sèks · Mizajou Sep 25, 2026 · NCT00001467A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Ap rekriteFaz 2
Laj 18 a 60 · Tout sèks · Mizajou Sep 25, 2026 · NCT07541287Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Month – 99 Years · Tout sèks · Mizajou Sep 22, 2026 · NCT00794352A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06722235Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 17, 2026 · NCT04242095METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
Ap rekriteFaz 2
Laj 18 a 69 · Tout sèks · Mizajou Sep 15, 2026 · NCT07699380(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04996875A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06948318PS-002 for the Treatment of IgA Nephropathy in Adults
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07182227A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07765888A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT07075185Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05826535A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
Ap rekriteFaz 1/2
Laj 35 a 70 · Tout sèks · Mizajou Aug 21, 2026 · NCT06575426Abatacept for the Treatment of Giant Cell Arteritis
Ap rekriteFaz 3
Laj 50 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT04474847A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT04104776Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Aug 17, 2026 · NCT07759115Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Aug 17, 2026 · NCT06858319A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Ap rekriteFaz 2
Laj 18 a 74 · Tout sèks · Mizajou Aug 12, 2026 · NCT07037901Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.